Yourgene Health plc | Exhibition

In lieu of having a physical stand, please find below a representation of us at our virtual stand. We have so much to be proud of.
Below are a few, handpicked key messages for our partners and customers.
Please do let us know if you would like us to arrange a virtual meeting to discuss further.

Yourgene Health delivers innovative in-vitro diagnostics across a growing range of products and services

Yourgene Health has launched its first infectious disease test – a molecular PCR-based COVID-19 assay. The Yourgene Health Clarigene SARS-CoV-2 test is a PCR-based COVID-19 assay to detect SARS-CoV-2 virus RNA targets to confirm the presence of the virus.

LEARN MORE

IONA^® Software and Sage™ Link – our NIPT bioinformatics solutions are well renowned and well respected. Yourgene Flex™ is a modular next-generation sequencing (NGS) analysis framework harnessing best in class bioinformatics pipelines.

LEARN MORE

Yourgene Genomic Services harnesses Yourgene’s core capabilities to build a global laboratory service network equipped to be a full life-cycle partner for clinical, research and pharmaceutical organisations.

We have created a service business that supports partners at the preclinical, clinical, and post-market stages as they develop, manufacture, obtain regulatory approval and commercialise new products and services.

LEARN MORE

Elucigene DPYD - the Group’s first oncology product, which is a simple genotyping test that can identify patients with DPD deficiency allowing an alternative treatment to be offered.

LEARN MORE

Our market leading PCR test for Cystic Fibrosis is the only commercially available pan-European Cystic Fibrosis testing kit designed specifically to address most common mutations found across populations of European origin.

LEARN MORE

Our Taipei service laboratory provides an oncology genetic analysis service with tests available predominantly for lung, colorectal and breast cancer.

LEARN MORE

World class experience in diagnostic development from launching the first CE-IVD non-invasive prenatal screening to driving companion diagnostic collaborations including FDA approval.

LEARN MORE

Our global team with extensive expertise, skills and industry knowledge spanning from non-regulated to highly regulated IVD manufacture and kitting capabilities to ensure the right product gets to the right customer on time.

LEARN MORE

An ever- growing range of products across the reproductive health journey that utilise different technologies, including PCR-based screening tests for Male Factor Infertility, Recurrent Pregnancy Loss and Genetic Thrombosis.

NEXT SCREEN

We offer a range of products for the management of reproductive health. We have developed genetic tools to investigate the cause of recurrent miscarriage and male infertility. Our PCR-based screening tests include Male Factor Infertility, Recurrent Pregnancy Loss and Genetic Thrombosis. Our QST*R Rapid Aneuploidy Analysis test can be carried out for Women that have a high-risk first trimester combined test or an NIPT.

LEARN MORE

Yourgene provides two complementary screening solutions, The IONA^® test and the Sage™ prenatal screen, to meet more of our lab customers’, clinicians’ and pregnant women’s needs across different international locations. The IONA^® test and the Sage™ prenatal screen.

NEXT SCREEN

Non-Invasive Prenatal Testing (NIPT)

Yourgene provides two complementary screening solutions to meet more of our lab customers', clinicians' and pregnant women's needs across different international locations.

The IONA^® test

The IONA^® test is the first CE marked in vitro diagnostic (IVD) for prenatal screening which allows clinical laboratories around the world to establish their own quality assured non-invasive prenatal screening service. The IONA^® test is registered as a regulated IVD in many different regions. The IONA® test is available as a service from Yourgene Laboratory Services in Manchester.

LEARN MORE

Sage™ prenatal screen

The Sage™ prenatal screen is available in additional regions where a regulated NIPT is not required for trisomy screening. Sage™ provides highly accurate screening results for a greater clinical depth of chromosomal conditions including trisomies, sex chromosomal aneuploidies, autosomal aneuploidies and some select microdeletions. The Sage™ prenatal screen is available as a service from Yourgene Laboratory Services in Taipei.

LEARN MORE